Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases October 30, 2024 Incyte to Present at Upcoming Investor Conferences October 29, 2024 Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs October 24, 2024 Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top Employers List All press releases Latest Events Nov 19 2024 Nov 19 2024 Jefferies London Healthcare Conference Click here for Webcast Nov 11 2024 Nov 11 2024 Guggenheim’s Inaugural Healthcare Innovation Conference Click here for Webcast All events
